Our Story

We had enough.

Mymee was conceived after years of feeling sick, alone and disempowered by a healthcare system that simply did not understand the nuanced challenges of autoimmune diseases.

Creating a mirror image

Understanding me.

The origin of the name “Mymee” is that our application is a “mime”, providing a clear mirror image of each person. From the very beginning, we knew that if we could capture a body’s signals and decode the hidden patterns, we could create the world’s first truly personalized approach to health optimization.

Rethinking Autoimmunity

The evolution into digital care.

The evolution from an idea into a digital solution for autoimmunity happened quite quickly. Within just a few years we had established the backend technology and data algorithms to allow Mymee to deliver a personalized solution to over a thousand participants.

Mymee Fast Facts

2017

Year founded

1,000

empower-black

Participants Helped

89

NPS Score

90

percent-black

program completion rate

2017

Year founded

1,000

empower-black

Participants Helped

89

NPS Score

90

percent-black

program completion rate

founder & ceo

Mette Dyhrberg.

Mette is a digital health innovator committed to improving the quality of life for those with chronic autoimmune disease. She is the founder and CEO of Mymee.

mette - no background

Executive team.

We believe in the power of Mymee, because we’ve seen the life-changing results ourselves. And we’re dedicated to building technology to improve today’s generic autoimmune treatments.

Nicole.

Chief Medical Officer

eric.

Chief Technology Officer

Melinda.

Chief Commercial Officer

mara.

General Counsel

Millennia.

Head of Coaching

We're proud to have been featured in these publications

the-wall-street-journal
newscientist
self
npr
healthtech-conference
smithsonian
motherjones
bbc-one
mdicineX
san-francisco-chronicle